Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate
- 2 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Bioenergetics and Biomembranes
- Vol. 44 (1), 31-38
- https://doi.org/10.1007/s10863-012-9412-9
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatmentsDisease Models & Mechanisms, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiformeThe Journal of Experimental Medicine, 2011
- Advances in the understanding of myeloma bone disease and tumour growthBritish Journal of Haematology, 2010
- Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvateBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapySeminars in Cancer Biology, 2009
- Atacicept (TACI-Ig) inhibits growth of TACIhigh primary myeloma cells in SCID-hu mice and in coculture with osteoclastsLeukemia, 2007
- Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondriaOncogene, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006